Since obesity is a chronic illness that can lead to type 2 diabetes, cardiovascular disease, certain cancers, and sleep disorders, the FDA responded by approving the use of semaglutide in increased dosages for treating obesity and overweight individuals with certain weight-related diseases
Benaiges D, Flores Le-Roux JA, Pedro-Botet J, Chillarn JJ, Renard M, Parri A, et al
In March 2024, Wegovy was also approved to reduce the risk of cardiovascular death, heart attack and stroke in adults with cardiovascular (heart, blood vessel) disease and either obesity or overweight
Methylcobalamin: Metabolites of vitamin B12 are formed by this process

Water/Aqua/Eau, Caprylic/Capric Triglyceride, Octyldodecanol, Glycerin, Polyester-7, Sorbitan Stearate, Steareth-20, Neopentyl Glycol Diheptanoate, Cetearyl Alcohol, Ethyl Ferulate, Tocopheryl Acetate, Bisabolol, Palmitoyl Glycine, Polysorbate 60, Isostearic Acid, Polyhydroxystearic Acid, Benzyl Alcohol, Ammonium Acryloyldimethyltaurate/Beheneth-25 Methacrylate Crosspolymer, Linum Usitatissimum (Linseed) Seed Oil, Sodium Citrate, 1,2-Hexanediol, Caprylyl Glycol, Fragrance (Parfum), Xanthan Gum, Salvia Hispanica Seed Oil, Macadamia Ternifolia Seed Oil, Ceramide NP, Citric Acid, Pentaerythrityl Tetra-Di-T-Butyl Hydroxyhydrocinnamate, S-Palmitoylglutathione, Methylglucoside Phosphate, Sodium Phytate, Copper Lysinate/Prolinate, Sodium Hydroxide, Ascorbyl Palmitate, Tocopherol, Helianthus Annuus (Sunflower) Seed Oil, Rosmarinus Officinalis (Rosemary) Leaf Extract, Limonene, Linalool, Hydroxycitronellal, Citronellol Massage onto cleansed face and neck using a gentle upward motion in the morning

10.1038/s41366-024-01500-y 9 BuckeridgeC.CobainS.BaysH